drugset / Trial / NCT00003008
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 2
Completed
33 enrolled
Eastern Cooperative Oncology Group
AIDS Associated Malignancies Clinical Trials Consortium · collabNational Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with AIDS-related Kaposi's sarcoma.
Timeline
- Start
- 1997-12-15
- Primary completion
- 2006-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INDINAVIR ANHYDROUS | Other / unclassified | — | — |
| Subject | Nelfinavir | Other / unclassified | — | — |
| Subject | Paclitaxel | Small molecule | — | Intravenous |
| Subject | Ritonavir | Other / unclassified | — | — |
| Subject | Saquinavir | Small molecule | — | — |